Abstract: Human enterovirus 71, a member of the Picornaviridae family, is one of the major causative agent of hand, foot and mouth disease in children less than six years old. This illness has caused mortalities in large-scale outbreaks in the Asia-Pacific region in recent years. No vaccine or antiviral therapy is available. In this study, antiviral effect of matrine against enterovirus 71 were evaluated in vitro and in vivo. Matrine could suppress the viral RNA copy number on rhabdomyosarcoma cells. Moreover, matrine treatment of mice challenged with a lethal dose of enterovirus 71 reduced the mortality and relieved clinical symptoms. The results showed that matrine may represent a potential therapeutic agent for enterovirus 71 infection.
This is an open access article distributed under the
Creative Commons Attribution License which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Export to BibTeX
MDPI and ACS Style
Yang, Y.; Xiu, J.; Zhang, X.; Zhang, L.; Yan, K.; Qin, C.; Liu, J. Antiviral Effect of Matrine against Human Enterovirus 71. Molecules 2012, 17, 10370-10376.
Yang Y, Xiu J, Zhang X, Zhang L, Yan K, Qin C, Liu J. Antiviral Effect of Matrine against Human Enterovirus 71. Molecules. 2012; 17(9):10370-10376.
Yang, Yajun; Xiu, Jinghui; Zhang, Xu; Zhang, Liangfeng; Yan, Kai; Qin, Chuan; Liu, Jiangning. 2012. "Antiviral Effect of Matrine against Human Enterovirus 71." Molecules 17, no. 9: 10370-10376.